U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07234682) titled 'Impact of Anxiety-Sleep Symptom Cluster on Immune Function and Quality of Life in Colorectal Cancer' on Sept. 28.
Brief Summary: This prospective observational study investigates the impact of the anxiety-sleep disturbance symptom cluster on cellular immune function and quality of life in colorectal cancer (CRC) patients undergoing chemotherapy. The study aims to determine if patients with clinically significant anxiety and sleep disturbance exhibit poorer immune cell profiles (e.g., T-cells, NK cells) and lower quality of life compared to patients with no or low symptoms.
Study Start Date: Jan. 01, 2024
Study Type: OBSERVATIONAL...